On 14 December 2018, orphan designation (EU/3/18/2106) was granted by the European Commission to AudioCure Pharma GmbH, Germany, for 6-fluoro-9-methyl-9H-pyrido[3,4-b]-indole for the treatment of sudden sensorineural hearing loss.
|Disease / condition||
Treatment of sudden sensorineural hearing loss
|Date of first decision||
|EU designation number||
Sponsor's contact details
For contact details of patients’ organisations whose activities are targeted at rare diseases, see:
European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.
- Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe;